Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2015-2017
Title: The Innovations of Dan J Trepanier
Introduction
Dan J Trepanier is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly through his work on cyclosporine analogues. With a total of 2 patents, Trepanier's innovations have the potential to impact immunosuppressive therapies.
Latest Patents
Trepanier's latest patents focus on cyclosporine analogue molecules modified at amino acids 1 and 3. These analogs of cyclosporin-A include modifications of the substituents at these positions, which are designed to have an affinity for cyclophilin, including cyclophilin-A. Notably, these compounds exhibit reduced immunosuppressivity compared to cyclosporin-A and its analogs modified solely at position 1. This advancement could lead to more effective treatments with fewer side effects.
Career Highlights
Throughout his career, Trepanier has worked with various companies, including Ciclofilin Pharmaceuticals Corp. and Contravir Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to the development of innovative pharmaceutical solutions.
Collaborations
Some of Trepanier's notable coworkers include Alexander Hegmans and Bruce W Fenske. Their collaborative efforts have furthered research and development in the pharmaceutical industry.
Conclusion
Dan J Trepanier's work exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the area of cyclosporine analogues, highlight the importance of research in developing new therapies. The impact of his patents may lead to significant advancements in immunosuppressive treatments.